Clinical Roundup Researchers develop tool that can identify high- and low-risk metastatic prostate cancer patients earlier January 23, 2026Vol.52 No.03
Clinical Roundup Researchers identify ideal duration of prostate cancer hormone therapy January 23, 2026Vol.52 No.03
Clinical Roundup Mayo develops AI tool that predicts prostate cancer recurrence January 16, 2026Vol.52 No.02
Clinical Roundup LSU researchers identify proteins linked to prostate cancer January 16, 2026Vol.52 No.02
Clinical Roundup Alliance prostate cancer trial seeks to reduce toxicity without sacrificing efficacy January 09, 2026Vol.52 No.1
Drugs & Targets FDA grants regular approval to rucaparib for metastatic castration-resistant prostate cancer December 19, 2025Vol.51 No.46
Clinical Roundup LSU researchers discover key immune differences in TNBC December 12, 2025Vol.51 No.45
Drugs & Targets FDA grants 501(k) clearance for Vanquish System for prostate tissue ablation in intermediate risk prostate cancer December 05, 2025Vol.51 No.44
Clinical Roundup Five genes linked to aggressive prostate cancer in men of African descent, USC study identifies November 07, 2025Vol.51 No.41
Clinical Roundup GammaTile delivers superior tumor control vs. standard-of-care for newly diagnosed operable brain metastases October 24, 2025Vol.51 No.39
